# Study of Incidence of Drug-induced Upper Gastrointestinal Bleeding

> **NCT01155401** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 300 (actual)

## Conditions studied

- Upper Gastrointestinal Bleeding

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01155401
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2011-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01155401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01155401, "Study of Incidence of Drug-induced Upper Gastrointestinal Bleeding". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01155401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*